Publication | Closed Access

Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study

VaccinationVaccine SafetyVaccinologyPreventive MedicineVaccine DevelopmentVaccine TestingInternational HealthInterim ResultsVaccine EfficacyLatin AmericaPublic HealthMedicineArbovirusEpidemiologyTetravalent Dengue Vaccine